NYSE · Medical - Healthcare Information Services

Veeva Systems Inc. (VEEV) Stock

$323.04 +0.15% NYSE: VEEV Healthcare

Valuation

MetricValue
Price$323.04
Market Cap$52.30B
P/E Ratio44.86
P/B Ratio6.09
P/S Ratio13.09
EPS (TTM)$5.44
52-Week High$324.17
52-Week Low$148.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE14.00%
ROA11.20%
ROCE13.61%
Gross Margin28.67%
Operating Margin28.67%
Net Margin29.34%
Debt/Equity0.02
Current Ratio4.89

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.9B$2.2B$2.4B$2.7B$3.2B
Operating Profit$505.0M$459.0M$429.0M$691.0M$916.0M
Net Profit$427.0M$488.0M$526.0M$714.0M$909.0M
EPS$2.63$3.00$3.22$4.32$5.44
Op Margin27.3%21.3%18.2%25.2%28.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$3.8B$4.8B$5.9B$7.3B$9.0B
Total Liabilities$905.0M$1.1B$1.3B$1.5B$1.8B
Cash$1.1B$886.0M$703.0M$1.1B$1.4B
Borrowings$55.0M$61.0M$56.0M$76.0M$96.0M

Latest News

Veeva Systems (VEEV) Could Be 41% Undervalued Following Russell Index Removal Simply Wall St. · Jul 10, 2026 Veeva Systems (VEEV) Launches Veeva EHS For Manufacturing And Testing Teams Simply Wall St. · Jul 9, 2026 2 Reasons to Watch VEEV and 1 to Stay Cautious StockStory · Jul 9, 2026 Veeva Systems (VEEV) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · Jul 8, 2026 Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 8, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$764.0M$780.0M$911.0M$1.1B$1.4B
Investing Cash Flow$-360.0M$-1.0B$-1.1B$-721.0M$-1.1B
Financing Cash Flow$-55.0M$-63.0M$-79.0M$-79.0M$-263.0M
Net Cash Flow$410.0M$-252.0M$-183.0M$414.0M$302.0M
Free Cash Flow$750.0M$767.0M$885.0M$1.1B$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio1.82
EV / EBITDA31.74
FCF Yield3.63%
Quick Ratio5.46
Interest Coverage—
Return 1Y10.05%
Return 3Y62.69%
Return 5Y-1.00%

Ownership

Insiders Held8.59%
Institutions Held89.64%
Institutions Float Held98.06%
Institutional HolderSharesReport Date
Blackrock Inc.11,558,8752026-03-31
Vanguard Portfolio Management LLC7,376,0312026-03-31
Vanguard Capital Management LLC6,670,3182026-03-31
Alliancebernstein L.P.6,271,0982026-03-31
Linonia Partnership LP4,924,6262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DOCSDoximity, Inc. $33.39 -0.86% 31.38 $5.95B 0.00%
HCTIHealthcare Triangle, Inc. $0.34 -11.36% -0.01 $5.02M 0.00%
HSTMHealthStream, Inc. $35.16 +1.65% 43.07 $1.08B 0.45%
IQVIQVIA Holdings, Inc. $279.36 +0.37% 31.76 $45.98B 0.00%
SDGRSchrodinger, Inc. $23.80 +5.31% -40.96 $1.78B 0.00%

About Veeva Systems Inc.

Veeva Systems Inc. is led by CEO Peter Gassner, employs 7,291 people, headquartered in Pleasanton, US, publicly traded since 2013.

Veeva Systems Inc. (VEEV) stock trades at $323.04 with a market capitalization of $52.30B. The stock is valued at a price-to-earnings (P/E) ratio of 44.86, price-to-book of 6.09, price-to-sales of 13.09. Over the past 52 weeks the stock has ranged between $148.05 and $324.17, and currently trades at or near its 52-week high.

On profitability, Veeva Systems Inc. generates a return on equity (ROE) of 14.00%, return on capital employed of 13.61%, an operating margin of 28.67%, a net profit margin of 29.34%.

In its most recent fiscal year, Veeva Systems Inc. reported annual revenue of $3.2B, net profit of $909.0M. Over the last 5 fiscal years, revenue grew at an average annual rate of 16.9%, and net profit grew at an average annual rate of 19.1%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.02 (debt below half of shareholders' equity), a current ratio of 4.89, total assets of $9.0B, $1.4B in cash and equivalents.

VEEV has an average daily trading volume of 1,877,425 shares, a beta of 0.97.

Veeva Systems Inc. by the numbers, 2017–2026

Between 2017 and 2026 Veeva Systems Inc. reported revenue of $544.0M rising to $3.2B, a change of +487.3% across 10 years. Compounded, revenue has grown 16.9% a year over five years, 14.0% over three, 16.3% over the last twelve months. Net profit rose to $909.0M.

Operating margin went from 22.2% in 2017 to 28.7% in 2026, a gain of 6.5 percentage points. The most recent net margin is 29.34%. On a trailing twelve-month basis to Jun '26, revenue is $3.5B and net profit $1.0B.

Borrowings stand at $96.0M, cash from operations was $1.4B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 12.8% over five years, and was 12.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Veeva Systems Inc. (VEEV) — frequently asked questions

What is Veeva Systems Inc. (VEEV) stock price today?

Veeva Systems Inc. (VEEV) is currently trading at $323.04, up 0.15% today.

What is VEEV P/E ratio?

Veeva Systems Inc.'s P/E ratio is 44.86. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is VEEV return on equity (ROE)?

Veeva Systems Inc.'s return on equity (ROE) is 14.00%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.

What is Veeva Systems Inc.'s market cap?

Veeva Systems Inc. has a market capitalization of $52.30B.

Does VEEV pay a dividend?

Veeva Systems Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does VEEV carry?

Veeva Systems Inc. has a debt-to-equity ratio of 0.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is VEEV's profit margin?

Veeva Systems Inc. reports a net profit margin of 29.34% — the share of revenue left after every cost, including tax and interest.

What sector is VEEV in?

Veeva Systems Inc. is classified under Healthcare, in the Medical - Healthcare Information Services industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is VEEV listed on?

Veeva Systems Inc. trades on NYSE under the ticker VEEV.

What is VEEV's 52-week range?

Over the last year Veeva Systems Inc. has traded between $148.05 and $324.17.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens VEEV currently matches

On the figures above, Veeva Systems Inc. passes the filters for 11 of our ready-made screens, among them Low Debt Stocks, High Profit Margin Stocks, High ROA Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksHigh Profit Margin StocksHigh ROA StocksLarge Cap StocksBlue Chip StocksHealthcare Stocks To BuyDebt Free StocksNYSE Listed StocksDebt to Equity Below 1 StocksHigh Current Ratio StocksLow Debt Large Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.